Loading market data...
Sunday, August 16, 2026
Back to HomeKorea StockPremiumAll Lotte Chemical coverage

Lotte Chemical (011170.KS) Q1 2026: ₩4.99T Revenue Rebounds 8% as Naphtha +21% Crushes Polymer Spreads

Share
Lotte Chemical (011170.KS) Q1 2026: ₩4.99T Revenue Rebounds 8% as Naphtha +21% Crushes Polymer Spreads

Lotte Chemical (011170.KS) Q1 2026: ₩4.99T Revenue Rebounds 8% as Naphtha +21% Crushes Polymer Spreads

Top-line recovery masks a deepening margin squeeze — raw material inflation outpaced product pricing across every core polymer segment, exposing structural fault lines in Southeast Asian operations

Source: Q1 2026 Quarterly Report — Filed April 2026 with DART | Consolidated Financial Statements | Unit: ₩ billions

Unlimited U.S.-market analysis, $9.99/month

Lotte Chemical (011170.KS) Q1 2026: ₩4.99T Revenue Rebounds 8% as Naphtha +21% Crushes Polymer Spreads

This article became available on June 28, 2026. Subscribe to read in full, or wait until September 26, 2026 when it becomes free.

Cancel anytime. Full refund within 7 days.

Access is tied to your account. Subscribe with the same email you sign up with — if you already paid, sign up with that email and it unlocks automatically.

NewsFinanceMarkets

Go deeper than the headline

You just read what happened. Here's how to read what it means.

Free daily briefing

The U.S. market, every morning — free

LineVest Daily lands in your inbox before every opening bell: the key U.S. markets stories, earnings, disclosures and foreign flows — in plain English. Free, no card required.

Get LineVest Daily — free →
This company

Full report on Lotte Chemical

We read Lotte Chemical's latest SEC filing in full — financials under US GAAP, governance, and what it means for the stock. PDF in your inbox within 3 hours.

$12 · one-time

Get the Lotte Chemical report
Every name you watch

Follow the whole market

Reading several U.S. stocks a week? Read every analysis article the moment it publishes — full daily U.S. market coverage plus the 90-day archive.

$9.99 · monthly

Subscribe

Independent journalism based on primary SEC filings — not investment advice. No brokerage affiliation.